Le pancréas bioartificiel : de l’espoir à l’avenir thérapeutique.
Bouaoun R, Jeandidier N., Pinget M., Sigrist S. Le pancréas bioartificiel : de l’espoir à l’avenir thérapeutique. Infusystems France, Vol.29, N°1, (2012) 1-5
Bouaoun R, Jeandidier N., Pinget M., Sigrist S. Le pancréas bioartificiel : de l’espoir à l’avenir thérapeutique. Infusystems France, Vol.29, N°1, (2012) 1-5
Barrientos R, Baltrusch S, Sigrist S, Legeay G, Belcourt A, Lenzen S. Kinetics of insulin secretion from min6 pseudoislets after encapsulation in a prototype device of a bioartificial pancreas. Horm Metab Res. (2009), 41(1):5-9
Legeay G.; Bertrand P.; Belcours A.; Kessler L. Membrane for encapsulation chamber of cells producing at least a biologically active substance and bioartificial organ comprising same. US2004137063 (A1) – (2004)
Csikós Zs, Kerekes K, Fazekas E, Kun S, Borbély J, Biopolymer based nanosystem for doxorubicin targeted delivery Am J Cancer Res Mar 1;7(3):715-726 2017
Polyak, A.; Hajdu, I.; Bodnar, M.; Trencsenyi, G.; Postenyi, Z.; Haasz, V.; Janoki, G.; Janoki, G. A.; Balogh, L.; Borbely, J., Tc-99m-labelled nanosystem as tumour imaging agent for SPECT and SPECT/CT modalities. International Journal of Pharmaceutics, 449 (1-2), 10-17. 2013
Hajdu, I.; Bodnar, M.; Trencsenyi, G.; Marian, T.; Vamosi, G.; Kollar, J.; Borbely, J., Cancer cell targeting and imaging with biopolymer-based nanodevices. International Journal of Pharmaceutics, 441 (1-2), 234-241. 2013
Polyak, A.; Hajdu, I.; Bodnar, M.; Dabasi, G.; Joba, R. P.; Borbely, J.; Balogh, L., Folate receptor targeted self-assembled chitosan-based nanoparticles for SPECT/CT imaging: Demonstrating a preclinical proof of concept. International Journal of Pharmaceutics, 474 (1-2), 91-94. 2014
Hajdu, I.; Trencsenyi, G.; Bodnar, M.; Emri, M.; Banfalvi, G.; Sikula, J.; Marian, T.; Kollar, J.; Vamosi, G.; Borbely, J., Tumor-specific Localization of Self-assembled Nanoparticle PET/MR Modalities. Anticancer Research, 34 (1A), 49-59. 2014
Cooper DK, Bottino R, Gianello P, Graham M, Hawthorne WJ, Kirk AD, et al. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Chapter 4: pre-clinical efficacy and complication data required to justify a clinical trial. Xenotransplantation 2016, 23(1) , 46-52.
Cooper DK, Matsumoto S, Abalovich A, Itoh T, Mourad N, Gianello P, et al. Progress in Clinical Encapsulated Islet Xenotransplantation. Transplantation 2016, 100(11), 2301-2308.